Skip to main content
. 2021 Jul 19;12:694853. doi: 10.3389/fimmu.2021.694853

Figure 6.

Figure 6

Loss- and gain-of-function variations in BTK kinase domain. (A) XLA-causing variants (cyan) are distributed all along the kinase domain. (B) Sites of ibrutinib resistance conferring amino acids C481 (red) and T474 (green) along with gain-of-function variants at positions 512, 513, 517 and 547 (yellow), note that variant at 474 alone and together with other variants lead to gain-of-function activities. The structures are for ibrutinib (pink) complex with BTK (5p9j).